--- title: "42 Biotech Investors in London (Nov 2026)" last_updated: "2026-11-05" rows: "42" free_rows: "21" source: "Official registers and each organization's own website" canonical: "https://theinvestordatabase.com/lists/biotech-investors-in-london/" --- # 42 biotech investors in London We list 42 biotech investors in London as of November 2026: each was checked on its own website or an official register, and the list was last checked on 5 Nov 2026. - 42 investors - 18 with a fund filing or dated deal in the last 12 months - 244 named decision-makers on file ## First 21 of 42 biotech investors in London | Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile | |---|---|---|---|---|---|---|---|---| | Sofinnova Partners | VC firm | France (London office) | Seed, Series A, Series B, Growth | Biotech, Healthtech, Fintech, Agritech | New fund, Nov 2025 | €4.0B (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/sofinnova-partners/ | | Highland Europe | VC firm | London, United Kingdom | Growth | Biotech, AI, Cybersecurity, SaaS | New fund, Jul 2026 | €1.1B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/highland-europe/ | | Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Biotech, Healthtech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/claret-capital-partners/ | | Empirical Ventures | SEIS/EIS fund | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Semiconductor, Deep Tech | New deal, Jul 2026 | £50M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/empirical-ventures/ | | UKI2S | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI, Deep Tech | New deal, Jul 2025 | £150M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/uki2s/ | | Advent Life Sciences | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech | New fund, May 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/advent-life-sciences/ | | Vsquared Ventures | VC firm | Germany (London office) | Pre-seed, Seed, Series A | Biotech, AI, Industrial Tech, Deep Tech | Portfolio news, Nov 2026 | | 2026-11-05 | https://theinvestordatabase.com/investors/vsquared/ | | Elbow Beach | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Climate Tech, Agritech | New deal, Oct 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/elbow-beach/ | | Calculus Capital | SEIS/EIS fund | London, United Kingdom | Growth | Biotech, Fintech, SaaS, Healthtech | Portfolio news, Jun 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/calculus-capital/ | | EMV Capital | VC firm | London, United Kingdom | Seed, Series A | Biotech, Healthtech, Fintech, Deep Tech | New deal, Jul 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/emv-capital/ | | SV Health Investors | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech, Medtech | New fund, May 2025 | $4.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/sv-health-investors/ | | Zinc | Accelerator | London, United Kingdom | Pre-seed | Biotech, Healthtech, AI, Climate Tech | Portfolio news, Jul 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/zinc/ | | Medicxi | VC firm | London, United Kingdom | Pre-seed, Seed, Series A, Series B, Late stage | Biotech, Healthtech | New fund, Nov 2025 | €500M (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/medicxi/ | | Future Planet Capital | VC firm | London, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Mobility | Portfolio news, Apr 2025 | $570M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/future-planet-capital/ | | Ventures Together | Angel network | London, United Kingdom | Seed | Biotech, AI, Fintech, Cybersecurity | Portfolio news, Oct 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/ventures-together/ | | IQ Capital | VC firm | London, United Kingdom | Pre-seed, Seed, Series A | Biotech, AI, Energy, Healthtech | Portfolio news, Aug 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/iq-capital/ | | Octopus Ventures | VC firm | London, United Kingdom | Pre-seed, Seed, Series A, Series B | Biotech, Fintech, Healthtech, Climate Tech | New deal, Feb 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/octopus-ventures/ | | Eight Roads | VC firm | London, United Kingdom | Series B, Growth | Biotech, Healthtech, SaaS, Fintech | | $450M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/eight-roads/ | | Twin Path Ventures | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, AI, Healthtech, Fintech | Portfolio news, Dec 2025 | | 2026-11-04 | https://theinvestordatabase.com/investors/twin-path-ventures/ | | LifeArc Ventures | Corporate VC | London, United Kingdom | Seed, Series A | Biotech, Healthtech, Medtech | | £1.3B (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/lifearc-ventures/ | | Syncona | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech | Portfolio news, Mar 2026 | | 2026-11-05 | https://theinvestordatabase.com/investors/syncona/ | You are seeing 21 of 42. The full list adds 21 more investors and 244 named decision-makers. Get all 42 investors and 244 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/biotech-investors-in-london This page: https://theinvestordatabase.com/lists/biotech-investors-in-london/ ## Method and limits - Source: No row on this list rests on an SEC filing. All 42 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research. - Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: an office in London. - Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. - Fill rates: Of 42 rows: stage 41, sector 42, fund size 13, website 42. In the paid file: named decision-makers on 38 rows, firm email on 26, LinkedIn page on 35, check size on 19. ## Questions ### How many biotech investors in London are there? We list 42 as of November 2026. 18 of the 42 have a fund filing or a dated deal in the last 12 months. ### Which biotech investors in London raised a new fund in the last 12 months? 2 of the 42 have a fund filing dated in the last 12 months: Highland Europe (Jul 2026) and Medicxi (Nov 2025). 18 of the 42 have a fund filing or a dated deal in that time. ### How do I contact biotech investors in London? The paid file holds 244 named decision-makers across 38 of these 42 and a firm email for 26. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website. ### Where does the data on biotech investors in London come from? All 42 rows were checked on the firm's own website, with official registers and national venture capital association directories as the starting point. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 5 Nov 2026 at the latest. The whole file is re-verified twice a year.